drugset / Trial / NCT01104545
A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will determine if MK-3614, given as single doses, is safe and well tolerated in healthy males and male participants with mild to moderate hypertension.
Timeline
- Start
- 2008-11-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-3614 | Unknown | 0.25 mg | Oral |
| Subject | MK-3614 | Unknown | 0.5 mg | Oral |
| Subject | MK-3614 | Unknown | 0.75 mg | Oral |
| Subject | MK-3614 | Unknown | 1.25 mg | Oral |